Latest Lead News

Orpheus Uranium Limited has raised $4.36 million through a share placement anchored by IsoEnergy’s $1.5 million investment, aiming to accelerate uranium exploration across three Australian states.

Hot Chili Limited has raised A$40 million through a heavily oversubscribed private placement to accelerate the development of its La Verde copper-gold discovery within the Costa Fuego project in Chile. The funding will support expanded feasibility studies, environmental approvals, and further drilling aimed at defining a higher-grade starter pit.

Cauldron Energy’s latest groundwater analysis at the Yanrey Uranium Project reveals low chloride and sulphate levels, affirming the site’s suitability for environmentally friendly in situ recovery uranium mining. This milestone supports the company’s plans to expand resources and advance towards production.

Micro-X has initiated installation of its first human pilot site for a portable Head CT scanner at Royal Melbourne Hospital, marking a pivotal step towards revolutionising stroke diagnosis with carbon nanotube technology.

Livium Ltd announces a further A$335,000 distribution from its 50% stake in the LieNA joint venture, following receipt of a substantial R&D tax incentive rebate for FY25. The joint venture remains well-funded through FY27, supporting ongoing lithium extraction technology development.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Patagonia Lithium Ltd has successfully raised A$2.9 million through a private placement, aiming to fast-track drilling and feasibility studies at its flagship Formentera Project in Argentina.

ION Video Ltd has strengthened its board with the return of its original inventor, Finbar O’Hanlon, alongside CEO Anthony Baker, as the company pivots to become foundational infrastructure for Video Superintelligence.

Krakatoa Resources has raised $1.25 million through a well-supported placement to fund the next phase of exploration at its high-grade Zopkhito Antimony-Gold Project, following promising drilling results that validate historic data.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.

Nimy Resources has dispatched its inaugural shipment of high-grade gallium ore from Western Australia to the United States, marking a significant step in establishing a secure Western supply chain for this critical mineral.